Physician profile
Armando Roca
NPI 1073511754
$1,232.85
in general payments reported to CMS, 2019-2025
21 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $410 · 2020: $130 · 2021: $38.20 · 2022: $366 · 2023: $185 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $289.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $277.37 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $141.02 | 2019-2023 | |
| Glaxosmithkline, LLC. | $128.59 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $97.73 | 2019-2025 | Airsupra, Breztri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $66.86 | 2019 | |
| Novo Nordisk INC | $63.78 | 2022 | |
| Edwards Lifesciences Corporation | $53.34 | 2025 | |
| Novartis Pharmaceuticals Corporation | $49.49 | 2021-2022 | |
| Amarin Pharma, INC. | $47.84 | 2019 | |
| Sunovion Pharmaceuticals INC. | $47.82 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $38.92 | 2022-2023 | Eliquis |
| Astellas Pharma US INC | $35.86 | 2022 | |
| Lilly USA, LLC | $30.23 | 2022-2023 | Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.84 | 2023 | Jardiance |
| Sumitomo Pharma America, INC. | $23.12 | 2023 | Gemtesa |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $22.21 | 2023 | Rexulti |
| Esperion Therapeutics, INC. | $20.18 | 2020 | |
| Amgen INC. | $17.53 | 2023 | Evenity |
| Forte Bio-Pharma LLC | $15.33 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.50 | 2019 | |
| Abbott Laboratories | $14.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Armando Roca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.